0501 GMT - ResMed is likely to counter September-quarter gross margin contraction by pushing through price increases over the remainder of its 2027 fiscal year, David L. Bailey of Morgan Stanley says. The analyst thinks that comments by the CPAP maker's management support his previously stated view that higher component costs will act as a headwind to margin expansion. He tells clients in a note that ResMed will likely raise prices after its fiscal first quarter, to meet its guidance for incremental gross margin expansion. MS keeps an equal-weight rating on ResMed's U.S.-listed stock and trims the target price by 0.9% to US$227.00. The stock last closed at US$211.94. ResMed's ASX-listed shares are up 4.0% at 30.02 Australian dollars. (stuart.condie@wsj.com)

0445 GMT - Qantas's bull at Macquarie will watch the Australian carrier's annual results for any information on plans for its ageing A380 craft. With elevated fuel prices and interest rates putting pressure on fiscal 2026 earnings, one of the investment bank's analysts tells clients that there have been signs from the airline that A380 workloads may shrink given materially higher operating costs. The analyst writes in a note that details could emerge at this month's earnings announcement. With fleet renewal already set to continue through fiscal 2028, craft retirement is seen at Macquarie as one of the levers Qantas could pull. Macquarie has an unchanged outperform rating on the stock and lowers its target price by 1.8% to 10.80 Australian dollars. Shares are down 1.4% at A$10.42. (stuart.condie@wsj.com)

0414 GMT - Treasury Wine Estates' annual earnings get a positive reaction at RBC following the Australian producer's multiyear downgrade cycle. Analyst Michael Toner tells clients in a note that fiscal 2026 earnings are stronger than both company guidance and consensus forecasts, and sees fiscal 2027 guidance implying a small upside to his prior expectations. As for the company's latest A$558.4 million in write-downs, Toner accepts that fallowing vineyards and rebalancing supply are necessary in a challenging demand environment. RBC has a last-published sector perform rating on the stock and a target price of 5.00 Australian dollars. Shares are up 4.8% at A$5.69. (stuart.condie@wsj.com)

0359 GMT - SGH's FY26 earnings, due Tuesday, will "be useful to calibrate expected weakness unfolding in housing and construction sectors," Morgan Stanley says. Australia's SGH has businesses in construction materials, mining services and equipment hire. Its results should help investors get a better sense of how markets that are less influenced by interest rates--such as defense, Olympics and state-based legacy infrastructure pipelines--are faring, says MS. "Investors will be focused on where management is seeing demand soften versus remaining resilient, and whether current earnings growth can be sustained as capex trends increasingly diverge across sectors," the bank says. Shares in SGH are down 1.1% at A$45.38. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

0357 GMT - CAR Group's bull at Jefferies points to the performance of the vehicle advertiser's U.S. business in delivering a stronger-than-expected group-level performance than some investors had feared. North American revenue rose 6% in Australian dollar terms, but analyst Roger Samuel points out in a note to clients that it grew 12% once currency moves are stripped out. He says it is surprising that CAR still expects fiscal 2027 North American revenue growth in the double digits, noting the continuing downturn in the market for recreational vehicles and trucks. Jefferies has a last-published buy rating on the stock and a target price of 32.30 Australian dollars. Shares are up 9.5% at A$29.58. (stuart.condie@wsj.com)

0338 GMT - CAR Group's bull at Citi wonders whether the vehicle advertiser's guidance for 11%-14% fiscal 2027 revenue growth is optimistic. Analyst Siraj Ahmed points out that the Australia-listed group's fiscal 2026 revenue came in at the bottom end of its guidance range despite being buoyed by acquisitions. Ahmed suggests that a weak macroeconomic backdrop might be a reason for pessimism. He is surprised at the strength in the company's shares following the result. Nonetheless, he tells clients in a note that CAR Group's ongoing product development should still underpin medium-term revenue growth in the double digits. Citi has a last-published buy rating on the stock and a target price of 30.60 Australian dollars. Shares are up 8.5% at A$29.31. (stuart.condie@wsj.com)

0243 GMT - Hillgrove Resources' new copper-hedging program is modest and adds a good level of support in case prices soften, according to analysts at MA Moelis Australia. They say it makes sense for Hillgrove to ensure a minimum price for some of its production. The volumes--Hillgrove hedged 3,600 metric tons over the 12 months--seem appropriate, they add. "While recent times have seen the market grow cautious of hedging in general, it is still incumbent upon companies to ensure appropriate risk mitigation," the analysts say. MA has a buy rating and a 9.5 Australian cents a share target on Hillgrove. The stock is down 0.8% at 6.35 Australian cents. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

0158 GMT - Shares in James Hardie are likely to remain driven by sentiment towards the U.S. housing cycle, says UBS. The bank sees "the timing and shape of any recovery dependent on improving consumer confidence and lower mortgage rates." James Hardie's FY27 guidance suggests a conservative 2H outlook, with no assumption of a macro recovery, says UBS. The bank upgrades its FY27 Ebitda forecast by 7% to US$1.628 billion, slightly above the top end of the company's guidance range. Longer term, UBS thinks there's "upside from the structural underbuild of U.S. housing and material conversion opportunities across siding and decking." The bank keeps a neutral rating on James Hardie's Australian shares, but raises its target price to 45.00 Australian dollars from A$40.00. Shares are down 1.3% at A$42.60. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

0111 GMT - Even James Hardie's upgraded earnings guidance appears conservative to Macquarie. Building-products company James Hardie raised FY 2027 adjusted Ebitda guidance to US$1.536 billion-US$1.625 billion. Macquarie forecasts US$1.637 billion. "We expect some late-FY27 recovery in activity, aided by multi-family pipelines and top-of-market R&R [repair and remodel] momentum," the bank says. Macquarie projects so-called commercial synergies to become a key driver of the company's share-price performance. "The evolution of supply chain and channel strategy, manufacturing efficiencies and the impact of sales integration (combined with expanded distributor relationships) all support this narrative," it says. Macquarie has an outperform rating on James Hardie's Australian shares. It raises its price target to A$47.10 from A$41.20. The stock is down 1.3% at A$42.63. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

0000 GMT - Pathology services provider Integral Diagnostics's preliminary result for FY 2026 looks disappointing. Integral signaled annual revenue of A$788 million-A$790 million. That fell short of consensus hopes for A$799 million. Operating Ebitda of A$164 million-A$165 million missed market expectations for A$169 million. "While we had flagged downside risks to consensus numbers in our preview note, we expect the operating miss to be taken negatively by the market," says RBC Capital Markets. It had an outperform call and A$2.85/share price target on Integral entering this week. Integral ended Friday at A$2.18. (david.winning@wsj.com; @dwinningWSJ)

2355 GMT - Nick Scali's bull at Macquarie stays focused on the medium term while also putting the spotlight on the defensiveness of the Australian furniture retailer's balance sheet. Macquarie sees limited opportunity for earnings growth over FY 2027, predicting a 0.4% fall. "However, we see value in Nick Scali on a 1-3 year view," Macquarie says. U.K. growth is slow, but the product and gross-margin strategy is working. Its brand and market share in Australia and New Zealand are relatively robust, supported by continued advertising and no discounting. Meanwhile, Nick Scali is net cash to the tune of A$35 million and its dividend is growing. Macquarie highlights the option of doing more M&A, such as a third brand in Australia and small 4-5 store networks in the U.K. It retains an outperform call on Nick Scali. (david.winning@wsj.com; @dwinningWSJ)

2324 GMT - Macquarie says there's lots to like about Charter Hall Retail REIT except its stock is approaching a two-year high. The bank downgrades Charter Hall Retail REIT to neutral, from underperform, even as its FY26-28 operating EPS compound annual growth rate of 3.5% appeals. Macquarie also likes its dividend yield of 7%. Charter Hall Retail REIT ended last week at A$4.23, above Macquarie's A$4.18/share price target.(david.winning@wsj.com; @dwinningWSJ)

2226 GMT - Charter Hall Retail REIT's earnings guidance looks conservative to Jefferies. The Australian mall owner signaled operating EPS would be at least 27.3 Australian cents per unit in FY27. That would represent growth of 3.5%. Jefferies upgrades its FY27 EPS forecast by 2% to 28.0 cents. "A conservative FY27 guide with additional earnings and net tangible assets upside to come from further CCRF deployment and the September CPI rent review," analyst Andrew Dodds says. CCRF is the Charter Hall Convenience Retail Fund, which owns 24 shopping centers and 15 Bunnings warehouses. Jefferies lifts its price target by 13% to A$4.77/share. Charter Hall Retail REIT ended last week at A$4.23. "With valuation appealing and highly secure income growth on offer, we remain Buy rated," Jefferies says.